Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Polymeric micelles are compatible with high-throughput screening

Abstract:
HTS application of QBI Life Sciences’ PreserveX™ Polymeric Micelles could be major breakthrough in pharmaceutical research

Preliminary research shows Preservex™ polymeric micelles are compatible with high-throughput screening

Madison, WI | Posted on June 07, 2006

QBI Life Sciences, a leader in membrane protein research, announced today the results from initial screening of UGT1A1 that revealed the compatibility of PreserveX™ Polymeric Micelles with high-throughput screening assays. The announcement was made during a presentation by Olga Trubetskoy, a QBI Life Sciences Research Fellow, at the International Society for the Study of Xenobiotics (ISSX) European annual meeting in Manchester, England.

The study, conducted with a University of Wisconsin – Madison library of 352 compounds, showed that incorporation of UGT1A1 into PreserveX™ Polymeric Micelles stabilizes UGT, resulting in reduced background and an expanded assay dynamic range. Additionally, light scattering is minimized. Additional screenings are expected to take place later this year.

The data collected from high-throughput screening of UGTs provide a foundation for discovery of novel UGT substrates and inhibitors and for predicting drug metabolism, toxicity, drug-drug, and herbal-drug interactions during drug discovery and in clinical trials.

“The application of PreserveX™ Polymeric Micelles to high-throughput screening could prove to be a tremendous advance in pharmaceutical research,” said Ralph Kauten, CEO of QBI Life Sciences. “Our products have the potential to bring greater accuracy and efficiency to the screening process, which we believe will radically change the metrics of drug discovery.”

Until now membrane proteins have not been well understood because the extraction of membrane proteins from their natural environment can reduce stability and therefore activity, making screening for biological responses problematic.

QBI Life Sciences’ line of PreserveX™ Polymeric Micelles gives researchers the ability to isolate, stabilize, and preserve activity of the membrane proteins which can lead to better drug discovery techniques, more accurate results and more efficiency in the screening process. QBI Life Sciences has developed valuable drug discovery tools including these membrane protein stabilizing reagents, as well as surface coatings for membrane proteins and optimal media for cell-surface proteins.

QBI Life Sciences, a division of Quintessence Biosciences, Inc., is the first and only company offering polymeric micelle solutions to study membrane proteins.

The work resulting in this discovery is being funded under a grant from the National Institutes of Health (NIH) under the NIH’s Roadmap for Medical Research.

For more information about PreserveX™ Polymeric Micelles or to learn more about QBI Life Sciences, log on to www.qbilifesci.com.

####

Contact:
Ralph Kauten
(608) 441-2950
RalphK@qbilifesci.com

Copyright © QBI Life Sciences

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanomedicine shines light on combined force of nanomedicine and regenerative medicine March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Materials/Metamaterials

Wrapping carbon nanotubes in polymers enhances their performance: Scientists at Japan's Kyushu University say polymer-wrapped carbon nanotubes hold much promise in biotechnology and energy applications March 30th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Chemists make new silicon-based nanomaterials March 27th, 2015

UT Dallas engineers twist nanofibers to create structures tougher than bulletproof vests March 27th, 2015

Announcements

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE